These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26227779)

  • 21. Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.
    Gianotti M; Botta M; Brough S; Carletti R; Castiglioni E; Corti C; Dal-Cin M; Delle Fratte S; Korajac D; Lovric M; Merlo G; Mesic M; Pavone F; Piccoli L; Rast S; Roscic M; Sava A; Smehil M; Stasi L; Togninelli A; Wigglesworth MJ
    J Med Chem; 2010 Nov; 53(21):7778-95. PubMed ID: 20942472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles.
    Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H
    Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New halogenated tris-(phenylalkyl)amines as h5-HT2B receptor ligands.
    Kapadia N; Ahmed S; Harding WW
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3216-3219. PubMed ID: 27261181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6-Acetyl-5-hydroxy-4,7-dimethylcoumarin derivatives: Design, synthesis, modeling studies, 5-HT
    Ostrowska K; Leśniak A; Karczyńska U; Jeleniewicz P; Głuch-Lutwin M; Mordyl B; Siwek A; Trzaskowski B; Sacharczuk M; Bujalska-Zadrożny M
    Bioorg Chem; 2020 Jul; 100():103912. PubMed ID: 32388437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part 4.
    Herold F; Król M; Kleps J; Nowak G
    Eur J Med Chem; 2006 Jan; 41(1):125-34. PubMed ID: 16263195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of fused bicyclic heterocycles as potent and selective 5-HT(2A) receptor antagonists for the treatment of insomnia.
    Xiong Y; Ullman B; Choi JS; Cherrier M; Strah-Pleynet S; Decaire M; Feichtinger K; Frazer JM; Yoon WH; Whelan K; Sanabria EK; Grottick AJ; Al-Shamma H; Semple G
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1870-3. PubMed ID: 22325948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter.
    Seo HJ; Park EJ; Kim MJ; Kang SY; Lee SH; Kim HJ; Lee KN; Jung ME; Lee M; Kim MS; Son EJ; Park WK; Kim J; Lee J
    J Med Chem; 2011 Sep; 54(18):6305-18. PubMed ID: 21823597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and 5-HT1A/5-HT2A receptor activity of new N-[3-(4-phenylpiperazin-1-yl)-propyl] derivatives of 3-spiro-cyclohexanepyrrolidine-2,5-dione and 3-spiro-beta-tetralonepyrrolidine-2,5-dione.
    Obniska J; Pawłowski M; Kołaczkowski M; Czopek A; Duszyńska B; Klodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Pol J Pharmacol; 2003; 55(4):553-7. PubMed ID: 14581713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.
    Runyon SP; Mosier PD; Roth BL; Glennon RA; Westkaemper RB
    J Med Chem; 2008 Nov; 51(21):6808-28. PubMed ID: 18847250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and 5-HT1A/5-HT2A receptor activity of N-(4-arylpiperazin-1-yl)alkyl derivatives of 2-azaspiro([4.4]nonane and [4.5]decane-1,3-dione.
    Obniska J; Tatarczyńska E; Nikiforuk A; Charakchieva-Minol S; Duszyńska B
    Pharmacol Rep; 2006; 58(1):107-14. PubMed ID: 16531637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural combination of established 5-HT(2A) receptor ligands: new aspects of the binding mode.
    Kramer V; Herth MM; Santini MA; Palner M; Knudsen GM; Rösch F
    Chem Biol Drug Des; 2010 Oct; 76(4):361-6. PubMed ID: 20636331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel mannich bases, 5-arylimidazolidine-2,4-dione derivatives with dual 5-HT(1A) receptor and serotonin transporter affinity.
    Czopek A; Kołaczkowski M; Bucki A; Byrtus H; Pawłowski M; Siwek A; Bojarski AJ; Bednarski M; Wróbel D; Wesołowska A
    Arch Pharm (Weinheim); 2013 Feb; 346(2):98-109. PubMed ID: 23288448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological Characterization of H05, a Novel Serotonin and Noradrenaline Reuptake Inhibitor with Moderate 5-HT
    Xu X; Wei Y; Guo Q; Zhao S; Liu Z; Xiao T; Liu Y; Qiu Y; Hou Y; Zhang G; Wang K
    J Pharmacol Exp Ther; 2018 Jun; 365(3):624-635. PubMed ID: 29615471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 9-substituted 1,2,3,4-tetrahydro-beta-carbolin-1-ones, new 5-HT1A and 5-HT2A receptor ligands.
    Mokrosz MJ; Boksa J; Charakchieva-Minol S; Wesołowska A; Borycz J
    Pol J Pharmacol; 1999; 51(4):351-6. PubMed ID: 10540967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New 4-[omega-(diarylmethylamino)alkyl]- and 4-[omega-(diarylmethoxy)alkyl]-1-arylpiperazines as selective 5-HT1A/5-HT2A receptor ligands with differentiated in vivo activity.
    Paluchowska MH; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
    Pol J Pharmacol; 2004; 56(6):743-54. PubMed ID: 15662087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1,4-Benzoxazin-3(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands; the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity.
    Mokrosz MJ; Kowalski P; Kowalska T; Majka Z; Duszyńska B; Charakchieva-Minol S; Szaro A; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol; 1998; 50(4-5):333-40. PubMed ID: 10091718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of novel multiple-acting ligands towards SERT and 5-HT2C receptors.
    Eliás O; Agai-Csongor E; Domány G; Keserű GM; Gere A; Kiss B; Hellinger E; Vastag M; Gyertyán I
    Bioorg Med Chem Lett; 2014 May; 24(9):2118-22. PubMed ID: 24717153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides. 8.1, 2 synthesis and pharmacological evaluation of tricyclic fused quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides as potential alpha1-adrenoceptor antagonists.
    Chern JW; Tao PL; Wang KC; Gutcait A; Liu SW; Yen MH; Chien SL; Rong JK
    J Med Chem; 1998 Aug; 41(17):3128-41. PubMed ID: 9703460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1,4-Disubstituted aromatic piperazines with high 5-HT2A/D2 selectivity: Quantitative structure-selectivity investigations, docking, synthesis and biological evaluation.
    Möller D; Salama I; Kling RC; Hübner H; Gmeiner P
    Bioorg Med Chem; 2015 Sep; 23(18):6195-209. PubMed ID: 26299826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel serotonin 5-HT
    Czopek A; Kubacka M; Bucki A; Siwek A; Filipek B; Pawłowski M; Kołaczkowski M
    Pharmacol Rep; 2021 Oct; 73(5):1361-1372. PubMed ID: 34115343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.